Covetrus Expands Prescription Management Relationship with National Veterinary Associates

Named a preferred partner for prescription management services for their network of nearly 600 hospitals

PORTLAND, Maine–(BUSINESS WIRE)–Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced that it has been named a preferred prescription management partner for National Veterinary Associates (NVA), one of the largest owner and operators of veterinary hospitals in the United States.

Serving as a preferred partner, NVA will endorse the Covetrus prescription management platform to their rapidly growing network of nearly 600 practices across the United States.

“We have seen firsthand how using Covetrus’ prescription management platform can improve compliance and drive financial success,” said Erik Philipp, senior director of category management at NVA. “With this expanded partnership, we are looking forward to giving our hospitals and clients more convenient options to get the medications our patients need.”

“We are very enthusiastic about this enhanced relationship with NVA and continuing our successful collaboration with a growing number of their existing practices,” said Georgia Wraight, senior vice president and president, Covetrus Global Prescription Management. “As we continuously invest in new technology, workflow and capabilities to make prescription management easier, we are excited about the significant opportunities to better help thousands of NVA veterinarians drive improved compliance and better practice health.”

Covetrus’ prescription management platform, which is deeply integrated into the veterinary practice management software workflow, leverages insight and analytics, client engagement services and integrated pharmacy services to improve medical compliance. By working directly with veterinary practices to manage gaps in care, Covetrus is empowering veterinarians with insights and tools to create new revenue opportunities, enhance their client relationships and improve quality of care.

About Covetrus 

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. For more information about Covetrus visit https://www.covetrus.com.

Forward-Looking Statements

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our, plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the SEC. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

Contacts

Nicholas Jansen, Investor Relations

nicholas.jansen@covetrus.com | (207) 550-8106

Kiní Schoop, Public Relations 

kini.schoop@covetrus.com | (207) 550-8018

Staff

Recent Posts

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

9 hours ago

After Trump’s Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ’s Writ of Mandamus?

After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings

Boards and executive buyers are raising the 2026 bar for all product and service rankings…

1 day ago

Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients

Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…

1 day ago